CIGB-552: A new penetrating peptide with antitumor action mediated by the increased levels of the COMMD1 protein in cancer cell lines
|
|
Biotecnología Aplicada. 2015 jul.-sep.; 32(3) |
3501
|
Texto Completo(PDF-321 KB)
Cómo citar |
|
|
|
Demonstration of safety, immunogenicity and evidences of efficacy of the therapeutic vaccine candidate HeberNasvac and characterization of chronic hepatitis B patient populations
|
|
Biotecnología Aplicada. 2015 jul.-sep.; 32(3) |
3511
|
Texto Completo(PDF-195 KB)
Cómo citar |
|
|
|
Increased bioavailability of IFN a 2b modified by chemical conjugation to a two-branched polyethyleneglycol molecule
|
|
Biotecnología Aplicada. 2015 jul.-sep.; 32(3) |
3521
|
Texto Completo(PDF-208 KB)
Cómo citar |
|
|
|